Views & Analysis Frontiers Health 2019 – day two Digital health innovation conference Frontiers Health continues its 2019 run on Thursday 14 November at the Frank Gehry-designed AXICA Congress and Conference in Berlin.
News Novartis sets sights on new oral MS drug after phase 3 wins Novartis' oral BTK inhibitor remibrutinib has shown efficacy in a pair of phase 3 trials in multiple sclerosis, boosting its blockbuster credentials.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.